Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced and Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06480552
What this trial is testing

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
Teva Branded Pharmaceutical Products R&D LLC 240
Testing effectiveness (Phase 2)Study completedNCT00598975
What this trial is testing

NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)

Who this might be right for
TumorColorectal Cancer
Nektar Therapeutics 18
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06792435
What this trial is testing

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

Who this might be right for
Pancreatic Adenocarcinoma MetastaticLung Cancer (NSCLC)Ovarian Cancer+4 more
Astellas Pharma Global Development, Inc. 240
Early research (Phase 1)Looking for participantsNCT05746897
What this trial is testing

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Who this might be right for
Ovarian CancerMelanomaTriple Negative Breast Cancer+1 more
Hefei TG ImmunoPharma Co., Ltd. 38
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Early research (Phase 1)Looking for participantsNCT07137416
What this trial is testing

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+13 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07318649
What this trial is testing

Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Suzhou Genhouse Bio Co., Ltd. 120
Testing effectiveness (Phase 2)UnknownNCT05028478
What this trial is testing

CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorHematologic Malignancies
Curon Biopharmaceutical (Australia) Co Pty Ltd 164
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Early research (Phase 1)Looking for participantsNCT07763652
What this trial is testing

BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 22
Early research (Phase 1)Ended earlyNCT01296555
What this trial is testing

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Who this might be right for
Solid CancersNon-Hodgkin's Lymphoma
Genentech, Inc. 674
Early research (Phase 1)Looking for participantsNCT07545356
What this trial is testing

KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Kivu Bioscience Inc. 76
Large-scale testing (Phase 3)Study completedNCT03465722
What this trial is testing

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Who this might be right for
GIST
Blueprint Medicines Corporation 476
Testing effectiveness (Phase 2)Temporarily pausedNCT05416749
What this trial is testing

A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd. 216
Early research (Phase 1)Looking for participantsNCT06612840
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Early research (Phase 1)Study completedNCT04050709
What this trial is testing

QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor
ImmunityBio, Inc. 16
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Early research (Phase 1)Study completedNCT00834704
What this trial is testing

Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Halozyme Therapeutics 14
Next Page